APA

Jain T., Sauter C. S., Shah G. L., Maloy M. A., Chan J., Scordo M., Avecilla S. T., Batlevi Y., Dahi P. B., Batlevi C. W., Lia Palomba M., Giralt S. A. & Perales M. (20200203). Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. : Leukemia.

Chicago

Jain Tania, Sauter Craig S, Shah Gunjan L, Maloy Molly A, Chan Jason, Scordo Michael, Avecilla Scott T, Batlevi Yakup, Dahi Parastoo B, Batlevi Connie W, Lia Palomba M, Giralt Sergio A and Perales Miguel-Angel. 20200203. Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. : Leukemia.

Harvard

Jain T., Sauter C. S., Shah G. L., Maloy M. A., Chan J., Scordo M., Avecilla S. T., Batlevi Y., Dahi P. B., Batlevi C. W., Lia Palomba M., Giralt S. A. and Perales M. (20200203). Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. : Leukemia.

MLA

Jain Tania, Sauter Craig S, Shah Gunjan L, Maloy Molly A, Chan Jason, Scordo Michael, Avecilla Scott T, Batlevi Yakup, Dahi Parastoo B, Batlevi Connie W, Lia Palomba M, Giralt Sergio A and Perales Miguel-Angel. Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. : Leukemia. 20200203.